Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

19.6K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
19.6K
Cancer Therapies02:49

Cancer Therapies

10.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.6K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

7.4K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.4K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

9.1K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K
Peroxisomes01:24

Peroxisomes

22.2K
Peroxisomes are specialized organelles present in fungi, plant, and animal cells. It can vary in number, size, morphology, and activity depending on the type of tissue and the nutritional state of the cell. For example, cells with active lipid metabolism, such as adipocytes, neurons, and hepatocytes, have more peroxisomes than other cells in the body. Besides their primary role in breaking down complex organic molecules, peroxisomes can also synthesize specific macromolecules and participate in...
22.2K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

6.2K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Chain relationship between cumulative ecological risk and physical activity pattern on college students mediated by exercise atmosphere and self-control.

Scientific reports·2025
Same author

Longitudinal modeling of red blood cell distribution width dynamics and mortality risk in critically Ill patients with sepsis-associated acute kidney injury.

PloS one·2025
Same author

Clinical trials and advanced MRI techniques with stem cell therapy for ischemic stroke: present and future perspectives.

Journal of translational medicine·2025
Same author

Quantitative evaluation of China's new health insurance payment policy based on the policy modeling consistency (PMC) index model.

BMC health services research·2025
Same author

Decoding Rhizosphere Synergies: <i>Pseudomonas</i> and <i>Bacillus</i> Enhance Microbiome-Mediated Suppression of <i>Rhizoctonia solani</i> in Sugar Beet.

Phytopathology·2025
Same author

Microglia/macrophage-specific deletion of TLR-4 protects against neural effects of diet-induced obesity in a sexually dimorphic manner.

Journal of neuroinflammation·2025

Related Experiment Video

Updated: Apr 5, 2026

Analysis of Oxidative Stress in Zebrafish Embryos
11:05

Analysis of Oxidative Stress in Zebrafish Embryos

Published on: July 7, 2014

38.5K

Increased Oxidative Stress as a Selective Anticancer Therapy.

Jiahui Liu1, Zhichong Wang1

  • 1State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, 54 Xian Lie Nan Road, Guangzhou 510060, China.

Oxidative Medicine and Cellular Longevity
|August 15, 2015
PubMed
Summary

Reactive oxygen species (ROS) are crucial in cancer stem cell (CSC) survival and proliferation, especially under hypoxia. Exogenous ROS generation may selectively kill cancer cells by exploiting their sensitivity to oxidative stress.

More Related Videos

Imaging Approaches to Assessments of Toxicological Oxidative Stress Using Genetically-encoded Fluorogenic Sensors
09:33

Imaging Approaches to Assessments of Toxicological Oxidative Stress Using Genetically-encoded Fluorogenic Sensors

Published on: February 7, 2018

8.0K
Analyzing Oxidative Stress in Murine Intestinal Organoids using Reactive Oxygen Species-Sensitive Fluorogenic Probe
09:31

Analyzing Oxidative Stress in Murine Intestinal Organoids using Reactive Oxygen Species-Sensitive Fluorogenic Probe

Published on: September 17, 2021

4.9K

Related Experiment Videos

Last Updated: Apr 5, 2026

Analysis of Oxidative Stress in Zebrafish Embryos
11:05

Analysis of Oxidative Stress in Zebrafish Embryos

Published on: July 7, 2014

38.5K
Imaging Approaches to Assessments of Toxicological Oxidative Stress Using Genetically-encoded Fluorogenic Sensors
09:33

Imaging Approaches to Assessments of Toxicological Oxidative Stress Using Genetically-encoded Fluorogenic Sensors

Published on: February 7, 2018

8.0K
Analyzing Oxidative Stress in Murine Intestinal Organoids using Reactive Oxygen Species-Sensitive Fluorogenic Probe
09:31

Analyzing Oxidative Stress in Murine Intestinal Organoids using Reactive Oxygen Species-Sensitive Fluorogenic Probe

Published on: September 17, 2021

4.9K

Area of Science:

  • Oncology
  • Cell Biology
  • Biochemistry

Background:

  • Reactive oxygen species (ROS) play a dual role in cancer, influencing tumorgenesis and progression.
  • Hypoxia in the tumor microenvironment elevates ROS, activating hypoxia-inducible factors (HIFs) in cancer stem cells (CSCs).
  • This activation promotes CSC marker upregulation and reduces intracellular ROS, enhancing CSC survival and proliferation.

Purpose of the Study:

  • To review the mechanisms of redox regulation in CSCs.
  • To elucidate the role of ROS in anticancer therapies.
  • To explore the potential of exogenous ROS generation for selective cancer treatment.

Main Methods:

  • Literature review of studies on ROS, HIFs, CSCs, and redox regulation.
  • Analysis of the interplay between hypoxia, ROS, and CSC behavior.
  • Examination of the therapeutic implications of ROS modulation in cancer.

Main Results:

  • Elevated ROS under hypoxia drives HIF expression in CSCs, promoting their survival and proliferation.
  • Cancer cells exhibit higher ROS levels than normal cells and may be more sensitive to oxidative stress.
  • Antioxidant defense mechanisms in cancer cells are potent but ROS levels remain elevated.

Conclusions:

  • Redox regulation in CSCs is a critical factor in cancer progression.
  • Targeting ROS pathways presents a promising strategy for selective cancer therapy.
  • Exogenous ROS generation therapy holds potential for selectively eliminating cancer cells without harming normal tissues.